Synovetin OA® is a groundbreaking treatment developed by Exubrion Therapeutics, designed specifically to address canine osteoarthritis. This innovative injection targets the root cause of arthritis, which is inflammation, offering dogs long-lasting relief from pain for up to one full year. Unlike traditional treatments that merely mask symptoms, Synovetin OA works on a cellular level to eliminate harmful inflammatory cells within the joint, thereby preventing further joint damage over time. This minimally invasive procedure allows dogs to return home the same day, with no significant side effects commonly associated with systemic medications.

Veterinarians across the United States have endorsed Synovetin OA, reporting positive outcomes for 70% to 90% of treated dogs that exhibited signs of arthritis, such as limping and reduced mobility. This treatment's success stems from its ability to break the vicious cycle of inflammation, providing dogs with the opportunity to regain their joyful, active lifestyles. Synovetin OA represents a significant advancement in veterinary medicine, profoundly enhancing the quality of life for dogs suffering from arthritis.